KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Restructuring Costs (2016)

Historic Restructuring Costs for Rigel Pharmaceuticals (RIGL) over the last 3 years, with Q3 2016 value amounting to $5.8 million.

  • Rigel Pharmaceuticals' Restructuring Costs changed N/A to $5.8 million in Q3 2016 from the same period last year, while for Dec 2016 it was $7.4 million, marking a year-over-year change of. This contributed to the annual value of $1.3 million for FY2022, which is 6251.07% down from last year.
  • As of Q3 2016, Rigel Pharmaceuticals' Restructuring Costs stood at $5.8 million.
  • In the past 5 years, Rigel Pharmaceuticals' Restructuring Costs registered a high of $5.8 million during Q3 2016, and its lowest value of $1.7 million during Q3 2013.